TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic CancerLennart Versemann, Elisabeth Heßmann|Cancers|2022Cited by 17
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational TherapiesMarie C. Hasselluhn, Elisabeth Heßmann|Gastroenterology|2023Cited by 14
NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell ReprogrammingZhe Zhang, Elisabeth Heßmann|Cellular and Molecular Gastroenterology and Hepatology|2023Cited by 8
New Insights Into Pancreatic Cancer: Notes from a Virtual MeetingElisabeth Heßmann, Andreas Trumpp, Corinne Bousquet et al.|Gastroenterology|2021Cited by 5